WaratekVRT Sign in
Reset
More filters (1)
Columns
Including CVEs outside Waratek scope✕Product pip✕
Overview 4 matches · 0 in Waratek scope · 0 protected · 0 exploited · 0 CISA KEV · 0 public PoC · 0 EPSS ≥ 0.5
4matches 0in Waratek scope0.0% 0protected0.0% 0exploited0.0% 0CISA KEV0.0% 0public PoC0.0% 0EPSS ≥ 0.50.0%
Protected by Waratek 0 0.0% Rule in development 0 0.0% Mitigation candidate 0 0.0% No exploit published 0 0.0% Outside Waratek scope 0 0.0% Not applicable 4 100.0% Withdrawn CVE 0 0.0%
Critical 0 0.0% High 0 0.0% Medium 0 0.0% Low 4 100.0% None 0 0.0% Unknown 0 0.0%
blocked by ARMR today 0 0.0% partly blocked 0 0.0% not blocked 4 100.0% not established 0 0.0% unrecorded 0 0.0%
Exploited 0 0.0% Working exploit published 0 0.0% Proof of concept only 0 0.0% Forecast only 0 0.0% No public exploit 4 100.0%
4 matches Sign in to download these CVEs as CSV or JSON, or to follow them in a feed.
CVE Severity Published▾ Status Exploitation Description
CVE-2025-60912 Low 2025-12-08 Not applicable No public exploit phpIPAM v1.7.3 contains a Cross-Site Request Forgery (CSRF) vulnerability in the database export functionality. The generate-mysql.php function, located in the /app/admin/import-export/ endpoint, allows remote attackers to trigger large database dump downloads via crafted HTTP GET requests if an administrator has an active session.
CVE-2014-8991 Low 2014-11-24 Not applicable No public exploit pip 1.3 through 1.5.6 allows local users to cause a denial of service (prevention of package installation) by creating a /tmp/pip-build-* file for another user.
CVE-2013-1888 Low 2013-08-17 Not applicable No public exploit pip before 1.3 allows local users to overwrite arbitrary files via a symlink attack on a file in the /tmp/pip-build temporary directory.
CVE-2005-4494 Low 2005-12-22 Not applicable No public exploit Cross-site scripting (XSS) vulnerability in SPIP 1.8.2 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified parameters to (1) spip_login.php3 and (2) spip_pass.php3.